{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:52:10Z","timestamp":1791312730023,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.virol.2004.05.004","type":"journal-article","created":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T07:57:45Z","timestamp":1087372665000},"page":"425-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin"],"prefix":"10.1016","volume":"325","author":[{"given":"Edward","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Charles","family":"Whitbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sfyroera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Lambris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart N","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2004.05.004_BIB1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB2","first-page":"609","article-title":"Vaccinia gangrenosa treated with hyperimmune vaccinal gamma globulin","volume":"16","author":"Barbero","year":"1955","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2004.05.004_BIB3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2004.05.004_BIB4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.05.004_BIB5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.05.004_BIB6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2004.05.004_BIB7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.0042-9007.2004.00397.x","article-title":"Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia","volume":"86","author":"Goldsmith","year":"2004","journal-title":"Vox Sang."},{"issue":"9","key":"10.1016\/j.virol.2004.05.004_BIB8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2004.05.004_BIB9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/JVI.72.1.294-302.1998","article-title":"Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain","volume":"72","author":"Herrera","year":"1998","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2004.05.004_BIB10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2004.05.004_BIB11","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1994.1405","article-title":"Identification of a vaccinia virus penetration protein","volume":"202","author":"Ichihashi","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.virol.2004.05.004_BIB13","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1128\/jvi.66.12.7217-7224.1992","article-title":"Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope","volume":"66","author":"Isaacs","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinal gamma globulin: source, evaluation, and use in prophylaxis and therapy","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.virol.2004.05.004_BIB15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"issue":"Pt 1","key":"10.1016\/j.virol.2004.05.004_BIB16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/0022-1317-83-1-209","article-title":"Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread","volume":"83","author":"Law","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB17","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1128\/JVI.72.3.2429-2438.1998","article-title":"The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation","volume":"72","author":"Mathew","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","article-title":"Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus","volume":"50","author":"Payne","year":"1980","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.virol.2004.05.004_BIB19","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1128\/JVI.72.9.7091-7098.1998","article-title":"Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator","volume":"72","author":"Rux","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/978-1-4615-5331-1_51","article-title":"Extracellular enveloped vaccinia virus. Entry, egress, and evasion","volume":"440","author":"Smith","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virol.2004.05.004_BIB21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0022-3476(65)80221-9","article-title":"Complications of smallpox vaccination. Effects of vaccinia immune globulin therapy","volume":"67","author":"Sussman","year":"1965","journal-title":"J. Pediatr."},{"key":"10.1016\/j.virol.2004.05.004_BIB22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1099\/0022-1317-79-4-877","article-title":"Intracellular and extracellular vaccinia virions enter cells by different mechanisms","volume":"79","author":"Vanderplasschen","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB23","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.virol.2004.05.004_BIB24","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/jvi.67.8.4732-4741.1993","article-title":"Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination","volume":"67","author":"Wolffe","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2004.05.004_BIB25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204003113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682204003113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:31:50Z","timestamp":1758583910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682204003113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0042682204003113"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2004.05.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2004.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}